Deletion of TAK1 in the Myeloid Lineage Results in the Spontaneous Development of Myelomonocytic Leukemia in Mice

• Betty Lamothe,

  Affiliation Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
• YunJu Lai,

  Affiliation Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
• Lana Hur,

  Affiliation Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
• Natalia Martin Orozco,

  Affiliation Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
• Jing Wang,

  Affiliation Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
• Alejandro D. Campos,

  Affiliation Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
• Min Xie,

  Affiliation Department of Internal Medicine, The University of Texas Southwestern Medical Center, Dallas, Texas, United States of America

  ⨯
• Michael D. Schneider,

  Affiliation Faculty of Medicine, National Heart and Lung Institute, Imperial College London, London, United Kingdom

  ⨯
• Cynthia R. Lockworth,

  Affiliation Department of Veterinary Medicine and Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
• Jared Jakacky,

  Affiliation School of Health Professions, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
• Diep Tran,

  Affiliation School of Health Professions, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
• Michael Ho,

  Affiliation School of Health Professions, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
• Sity Dawud,

  Affiliation School of Health Professions, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
• Chen Dong,

  Affiliation Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
• Hui-Kuan Lin,

  Affiliation Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
• Peter Hu,

  Affiliation School of Health Professions, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
• Zeev Estrov,

  Affiliation Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
• Carlos E. Bueso-Ramos,

  Affiliation Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
•  [ ... ],
• Bryant G. Darnay

  * E-mail: bdarnay@mdanderson.org

  Affiliation Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
• [ view all ]
• [ view less ]